Balkrishan Kalra - 03 Mar 2026 Form 4 Insider Report for Genpact LTD (G)

Reporting relationship: President and CEO, Director
Issuer ticker: G
Reported as of: 03 Mar 2026
Net transaction value: -$114,156
SEC form: 4
Accepted by SEC: 05 Mar 2026, 16:43:27 UTC
Prior SEC filing: 03 Feb 2026
Next SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra

Key filing fact

Balkrishan Kalra filed Form 4 for Genpact LTD (G) on 05 Mar 2026.

Key facts

This page summarizes Balkrishan Kalra's Form 4 filing for Genpact LTD (G).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2026, 16:43.

Change

Previous filing in this sequence was filed on 03 Feb 2026.
Current net transaction value: -$114,156.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001768217 Primary reporting owner

Kalra Balkrishan

Relationship: President and CEO, Director
Address: C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

G transaction

Common Shares

Award

Transaction value
Shares: +27,160
Change %: +5.5%
Price: $0.000000^*
Shares after: 525,007
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1, F2

G transaction

Common Shares

Options Exercise

Transaction value
Shares: +2,800
Change %: +0.53%
Price: $27.65^*
Shares after: 527,807
Date: 04 Mar 2026
Ownership: Direct

G transaction

Common Shares

Sale

Transaction value: $114,156
Shares: -2,800
Change %: -0.53%
Price: $40.77
Shares after: 525,007
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

G transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -2,800
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Mar 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 2,800
Exercise price: $27.65
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date.

Footnote F2

Includes 587 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on February 3, 2026. The reporting person currently holds a total of 8,962 shares under the ESPP.

Footnote F3

The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.74 to $40.771. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F4

The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.